Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Willow Biosciences Inc
T.WLLW
Alternate Symbol(s):
CANSF
Consumer Cyclical
Healthcare
Technology
Advertising Agencies
Biotechnology
Software - Application
Cannabis
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial...
, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:WLLW)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Mar 23, 2022 5:17pm
RE:This stock is about to enter the 20s... Where is management?
Echo, echo, echo....The market for CBG is probably saturated and the demand is not there yet. Synthetic THC is dumb considering the abundance of THC in the plant. The analyst(s) covering Willow seem
...more
(24)
•••
throwaway11
X
View Profile
View Bullboard History
Post by
throwaway11
on Mar 22, 2022 6:20pm
This stock is about to enter the 20s... Where is management?
the company could at least just say they're still awake??
(14)
•••
jermiah777
X
View Profile
View Bullboard History
Comment by
jermiah777
on Mar 22, 2022 12:18am
RE:A look back
They are on anti-depressants or in a psych ward in a mental institution
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Mar 20, 2022 7:32am
A look back
Where did all the pumpers go? https://youtu.be/MhNHX3heCnA
(52)
•••
Corvette65
X
View Profile
View Bullboard History
Post by
Corvette65
on Feb 21, 2022 7:28pm
Wllw counter suit
Question has the court's decided on the original infringement against wllw. On the ceo.ca web site it has been said wllw has countered suited. Any info would be great
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 17, 2022 5:20am
InMed Update
InMed selling CBC and CBT. CBDV, THCV, CBGV and CBL will be selling within a few months. Maybe Willow and InMed should merge. https://mobile.twitter.com/inmedpharma
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 12, 2022 10:17pm
RE:RE:RE:webcast
Valens finally right-sizing the co. with layoffs and cost-cutting. Co. forecasts ebitda positive by end of 2022. Not impressed. Mgmt should have their salaries cut.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 12, 2022 9:48pm
Future Beyond CBD and THC
https://www.businesswire.com/news/home/20220210005401/en/Radicle-Science-Makes-History-Again-With-First-Large-Scale-Clinical-Trials-on-Rare-Cannabinoids-Including-THCV-CBN-CBG-and-CBC
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Feb 05, 2022 6:38am
RE:RE:RE:webcast
InMed Pharma will be reporting some revenues for the first time on 10 Feb and hopefully will give guidance going forward. So far they are supplying CBC and CBT with THCV and CBDV on the way. It's
...more
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 05, 2022 1:15am
RE:RE:webcast
The whole damn industry is avoiding giving any guidance. No visibility in an industry shake out.
(14)
•••
jermiah777
X
View Profile
View Bullboard History
Comment by
jermiah777
on Feb 05, 2022 1:06am
RE:webcast
I find that discouraging since the impression left over a year ago was that Willow is transitioning to a revenue generating company. Here we are and nothing stated about revenue? How much longer can
...more
(3)
•••
123600
X
View Profile
View Bullboard History
Post by
123600
on Feb 04, 2022 9:56am
webcast
lots of tech stuf and opportunities. nothing on revenue stream
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 04, 2022 6:10am
Cannabinoid Market
https://youtu.be/T8W72-JPYrs
(52)
•••
Corvette65
X
View Profile
View Bullboard History
Post by
Corvette65
on Feb 03, 2022 8:14pm
Any word
On the infringement in the presentation
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 31, 2022 7:48am
TO HOST INVESTOR PRESENTATION WEBCAST
VANCOUVER, BC, Jan. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income